期刊文献+

PCR-SSCP检测急性白血病患者N-ras基因突变及临床意义初探 被引量:2

Clinical significance of the detection of N-ras gene mutation in patients with acute leukemia by PCR-SSCP
下载PDF
导出
摘要 目的 探讨N ras基因突变与急性白血病发生的关系。方法 采取骨髓和外周血白细胞提取DNA ,用PCR SSCP分析技术分别对急性白血病患者、正常对照组的N ras基因突变进行检测。结果  84例急性白血病患者中 2 5例发生N ras基因突变 ,基因变异频率为 2 9 8% ,其中急性淋巴细胞白血病为 18 6% ,急性髓细胞白血病为 41 4% ;11例随访 6个月 ,7例N ras基因突变消失 ,4例N ras基因突变持续存在 ;正常对照组未发现N ras基因突变。结论 N Objective To explore the relationship between N ras mutation and the pathogenesis of acute leukemia. Methods Human genomic DNA was extracted from normal human peripheral white blood cell and bone marrow of patients. N ras gene mutations in 84 cases of acute leukemia and 50 normal healthy cases were detected by PCR SSCP technique, respectively. Results N ras gene mutations were found in 25 cases out of 84 cases of acute leukemia with the frequency of N ras gene variation being 29.8%, including 18.6% of acute lymphoblastic leukemia (ALL) and 41.4% of acute myelocytic leukemia(AML). After a follow up of 11 cases for 6 months, disappearance of N ras gene mutation was found in 7 cases but continuous presence of N ras gene mutation was found in 4 cases. However, no N ras gene mutation was found in 50 normal healthy cases. Conclusion N ras gene mutation is of important significance in the prognosis of patients with acute leukemia.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2003年第7期629-631,共3页 Journal of Third Military Medical University
关键词 N-RAS基因 急性白血病 突变 N ras gene acute leukemia mutation
  • 相关文献

参考文献2

  • 1张之南.血液病诊断及疗效标准[M].天津科学技术出版社,1999.172.
  • 2CW迪芬巴赫 等 黄培堂等(译).PCR技术实验指南[M].北京:科学出版社,1998,8..

共引文献30

同被引文献16

  • 1赖悦云,邱镜滢,江滨,卢锡京,黄晓军,刘艳荣,师岩,党辉,何琦,陆道培.t(8;21)急性髓性白血病72例的特征分析[J].北京大学学报(医学版),2005,37(3):245-248. 被引量:13
  • 2秦亚溱,李金兰,主鸿鹄,李玲娣,常艳,郝乐,阮国瑞,刘艳荣,黄晓军,陈珊珊.实时定量RT-PCR技术测定初治白血病患者常见融合基因转录子水平及其标准化的探讨[J].中华血液学杂志,2007,28(7):433-437. 被引量:26
  • 3Levis M.Recent advances in the development of small-molecule inhibitors for the treatment of acute myeloid leukemia.Curr Opin Hematol,2005,12(1):55-61.
  • 4Neubauer A,Dodge RK,George SL,et al.Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.Blood,1994,83(6):1603-1611.
  • 5Neubauer A,Maharry K,Mrózek K,et al.Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine:a Cancer and Leukemia Group B study.J Clin Oncol,2008,26(28):4603-4609.
  • 6Bennett JM,Catovsky D,Daniel MT,et al.Proposals for the classification of the acute leukaemias.French-American-British (FAB) cooperative group.Br J Haematol,1976,33(4):451-458.
  • 7Qin Y,Zhu H,Jiang B,et al.Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness fOr monitoring minimal residual disease.Leuk Res,2009,33(3):384-390.
  • 8Ruan GR,Li JL,Qin YZ,et al.Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia.Ann Hematol,2009,88(2):159-166.
  • 9Darley RL,Hoy TG,Baines P,et al.Mutant N-RAS induces erythroid lineage dysplasia in human CD34+cells.J Exp Med,1997,185(7):1337-1347.
  • 10Bowen DT,Frew ME,Hills R,et al.RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.Blood,2005,106(6):2113-2119.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部